These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33847741)

  • 41. Establishment and characterization of a novel MYC/BCL2 "double-hit" diffuse large B cell lymphoma cell line, RC.
    Pham LV; Lu G; Tamayo AT; Chen J; Challagundla P; Jorgensen JL; Medeiros LJ; Ford RJ
    J Hematol Oncol; 2015 Oct; 8():121. PubMed ID: 26515759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting BCL10 by small peptides for the treatment of B cell lymphoma.
    Bao W; Sun C; Sun X; He M; Yu H; Yan W; Wen F; Zhang L; Yang C
    Theranostics; 2020; 10(25):11622-11636. PubMed ID: 33052237
    [No Abstract]   [Full Text] [Related]  

  • 43. Preclinical efficacy and biological effects of the oral proteasome inhibitor ixazomib in diffuse large B-cell lymphoma.
    Liu W; Chen J; Tamayo AT; Ruan C; Li L; Zhou S; Shen C; Young KH; Westin J; Davis RE; Hu S; Medeiros LJ; Ford RJ; Pham LV
    Oncotarget; 2018 Jan; 9(1):346-360. PubMed ID: 29416618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Active IKKβ promotes the stability of GLI1 oncogene in diffuse large B-cell lymphoma.
    Agarwal NK; Kim CH; Kunkalla K; Konno H; Tjendra Y; Kwon D; Blonska M; Kozloski GA; Moy VT; Verdun RE; Barber GN; Lossos IS; Vega F
    Blood; 2016 Feb; 127(5):605-15. PubMed ID: 26603838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Curcumin Inhibits the Proliferation, Migration, Invasion, and Apoptosis of Diffuse Large B-Cell Lymphoma Cell Line by Regulating MiR-21/VHL Axis.
    Chen L; Zhan CZ; Wang T; You H; Yao R
    Yonsei Med J; 2020 Jan; 61(1):20-29. PubMed ID: 31887796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Smoothened stabilizes and protects TRAF6 from degradation: A novel non-canonical role of smoothened with implications in lymphoma biology.
    Qu C; Kunkalla K; Vaghefi A; Frederiksen JK; Liu Y; Chapman JR; Blonska M; Bernal-Mizrachi L; Alderuccio JP; Lossos IS; Landgraf R; Vega F
    Cancer Lett; 2018 Nov; 436():149-158. PubMed ID: 30165192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?
    Mondello P; Steiner N; Willenbacher W; Ferrero S; Ghione P; Marabese A; Pitini V; Cuzzocrea S; Mian M
    Oncologist; 2016 Sep; 21(9):1107-12. PubMed ID: 27382029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genome-wide CRISPR screen identifies noncanonical NF-κB signaling as a regulator of density-dependent proliferation.
    Fomicheva M; Macara IG
    Elife; 2020 Nov; 9():. PubMed ID: 33185187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of the intrinsic apoptosis pathway downstream of caspase-9 activation causes chemotherapy resistance in diffuse large B-cell lymphoma.
    Cillessen SA; Hess CJ; Hooijberg E; Castricum KC; Kortman P; Denkers F; Vos W; van de Wiel MA; Schuurhuis GJ; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
    Clin Cancer Res; 2007 Dec; 13(23):7012-21. PubMed ID: 18056177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The novel cereblon modulator CC-885 inhibits mitophagy via selective degradation of BNIP3L.
    Hao BB; Li XJ; Jia XL; Wang YX; Zhai LH; Li DZ; Liu J; Zhang D; Chen YL; Xu YH; Lee SK; Xu GF; Chen XH; Dang YJ; Liu B; Tan MJ
    Acta Pharmacol Sin; 2020 Sep; 41(9):1246-1254. PubMed ID: 32210356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5/miR-27b-3p/MET axis.
    Hu L; Zhao J; Liu Y; Liu X; Lu Q; Zeng Z; Zhu L; Tong X; Xu Q
    Int J Med Sci; 2020; 17(17):2735-2743. PubMed ID: 33162801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs.
    Lindner S; Steinebach C; Kehm H; Mangold M; Gütschow M; Krönke J
    J Vis Exp; 2019 May; (147):. PubMed ID: 31157769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries.
    Rocha CRR; Reily Rocha A; Molina Silva M; Rodrigues Gomes L; Teatin Latancia M; Andrade Tomaz M; de Souza I; Karolynne Seregni Monteiro L; Menck CFM
    Cells; 2020 Dec; 9(12):. PubMed ID: 33271924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay.
    Cillessen SA; Meijer CJ; Ossenkoppele GJ; Castricum KC; Westra AH; Niesten P; Muris JJ; Nijdam HF; van der Hem KG; Flens M; Hooijberg E; Oudejans JJ
    Br J Haematol; 2006 Aug; 134(3):283-93. PubMed ID: 16848771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Thalidomide therapy in relapsed diffuse large B-cell lymphoma in elderly patients. Three cases].
    Wohner N; Varga G; Szloboda P; Farkas P; Masszi A; Horváth L; Szombath G; Várkonyi J; Benedek S; Masszi T
    Orv Hetil; 2017 Oct; 158(41):1642-1648. PubMed ID: 29025286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma.
    Hansen JD; Correa M; Nagy MA; Alexander M; Plantevin V; Grant V; Whitefield B; Huang D; Kercher T; Harris R; Narla RK; Leisten J; Tang Y; Moghaddam M; Ebinger K; Piccotti J; Havens CG; Cathers B; Carmichael J; Daniel T; Vessey R; Hamann LG; Leftheris K; Mendy D; Baculi F; LeBrun LA; Khambatta G; Lopez-Girona A
    J Med Chem; 2020 Jul; 63(13):6648-6676. PubMed ID: 32130004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. β-Elemene suppresses tumor growth of diffuse large B-cell lymphoma through regulating lncRNA HULC-mediated apoptotic pathway.
    Hu T; Gao Y
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas.
    Bognar MK; Vincendeau M; Erdmann T; Seeholzer T; Grau M; Linnemann JR; Ruland J; Scheel CH; Lenz P; Ott G; Lenz G; Hauck SM; Krappmann D
    Oncogene; 2016 Aug; 35(32):4269-81. PubMed ID: 26776161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical significance of 'double-hit' and 'double-expression' lymphomas.
    Ma Z; Niu J; Cao Y; Pang X; Cui W; Zhang W; Li X
    J Clin Pathol; 2020 Mar; 73(3):126-138. PubMed ID: 31615842
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation.
    Herrera AF; Mei M; Low L; Kim HT; Griffin GK; Song JY; Merryman RW; Bedell V; Pak C; Sun H; Paris T; Stiller T; Brown JR; Budde LE; Chan WC; Chen R; Davids MS; Freedman AS; Fisher DC; Jacobsen ED; Jacobson CA; LaCasce AS; Murata-Collins J; Nademanee AP; Palmer JM; Pihan GA; Pillai R; Popplewell L; Siddiqi T; Sohani AR; Zain J; Rosen ST; Kwak LW; Weinstock DM; Forman SJ; Weisenburger DD; Kim Y; Rodig SJ; Krishnan A; Armand P
    J Clin Oncol; 2017 Jan; 35(1):24-31. PubMed ID: 28034071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.